Dataset Information


N-glycomic signature of stage II colorectal cancer and its association with the tumor microenvironment

ABSTRACT: The choice for adjuvant chemotherapy in stage II colorectal cancer (CRC) is controversial as many patients are cured by surgery alone and it is difficult to identify patients with high-risk of recurrence of the disease. There is a need for better stratification of this group of patients. Mass spectrometry imaging could identify patients at risk. We report here the N-glycosylation signatures of the different cell populations in a group of stage II CRC tissue samples.

INSTRUMENT(S): Bruker Daltonics flex series

ORGANISM(S): Homo sapiens  

TISSUE(S): Colon

DISEASE(S): Colon Cancer

SUBMITTER: Fanny Boyaval  

LAB HEAD: Heijs, Bram

PROVIDER: PXD021275 | Pride | 2020-10-21


Similar Datasets

2020-08-06 | PXD011104 | Pride
2020-10-15 | PXD020824 | Pride
2020-10-21 | PXD021682 | Pride
2019-04-12 | PXD010990 | Pride
2017-10-16 | PXD005960 | Pride
2020-11-16 | PXD020362 | Pride
2018-08-08 | PXD003172 | Pride
2019-05-06 | PXD013397 | Pride
2019-12-11 | PXD014310 | Pride
2019-06-10 | PXD013860 | Pride